237.12
price up icon0.27%   0.63
after-market Handel nachbörslich: 237.12
loading
Schlusskurs vom Vortag:
$236.49
Offen:
$238.39
24-Stunden-Volumen:
1.31M
Relative Volume:
1.02
Marktkapitalisierung:
$32.73B
Einnahmen:
$1.96B
Nettoeinkommen (Verlust:
$-253.24M
KGV:
-124.72
EPS:
-1.9012
Netto-Cashflow:
$94.06M
1W Leistung:
+8.60%
1M Leistung:
+23.17%
6M Leistung:
+54.66%
1J Leistung:
+40.87%
1-Tages-Spanne:
Value
$236.53
$241.28
1-Wochen-Bereich:
Value
$220.00
$241.28
52-Wochen-Spanne:
Value
$125.38
$241.28

Natera Inc Stock (NTRA) Company Profile

Name
Firmenname
Natera Inc
Name
Telefon
650-249-9090
Name
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Name
Mitarbeiter
4,434
Name
Twitter
@nateragenetics
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
NTRA's Discussions on Twitter

Vergleichen Sie NTRA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
NTRA
Natera Inc
237.12 32.64B 1.96B -253.24M 94.06M -1.9012
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
593.25 224.59B 43.74B 6.58B 6.11B 17.31
Diagnostics & Research icon
DHR
Danaher Corp
228.46 163.00B 24.27B 3.50B 5.02B 4.8589
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
755.96 61.22B 4.17B 1.03B 940.22M 12.61
Diagnostics & Research icon
A
Agilent Technologies Inc
154.37 44.50B 6.79B 1.22B 1.09B 4.2644
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
231.80 39.50B 15.90B 1.28B 2.21B 7.2842

Natera Inc Stock (NTRA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-27 Hochstufung BNP Paribas Exane Underperform → Neutral
2025-09-22 Fortgesetzt Wells Fargo Equal Weight
2025-03-13 Eingeleitet RBC Capital Mkts Outperform
2025-01-23 Eingeleitet Barclays Overweight
2024-06-03 Fortgesetzt Jefferies Buy
2024-04-08 Fortgesetzt Craig Hallum Buy
2024-02-20 Herabstufung Raymond James Strong Buy → Outperform
2023-12-29 Bestätigt BTIG Research Buy
2023-12-14 Eingeleitet Guggenheim Buy
2023-12-13 Eingeleitet Wolfe Research Outperform
2023-11-13 Hochstufung Raymond James Outperform → Strong Buy
2023-09-28 Eingeleitet Bernstein Mkt Perform
2023-07-05 Fortgesetzt JP Morgan Overweight
2023-05-05 Eingeleitet UBS Buy
2023-01-18 Hochstufung Raymond James Mkt Perform → Outperform
2022-08-25 Eingeleitet Credit Suisse Outperform
2022-04-25 Eingeleitet Stephens Overweight
2022-03-08 Eingeleitet Goldman Buy
2022-01-06 Fortgesetzt Piper Sandler Overweight
2021-10-15 Fortgesetzt Cowen Outperform
2021-06-15 Eingeleitet Raymond James Mkt Perform
2021-05-25 Eingeleitet Wells Fargo Overweight
2021-01-28 Eingeleitet Truist Buy
2020-10-08 Eingeleitet BTIG Research Buy
2020-09-28 Eingeleitet Morgan Stanley Overweight
2020-09-17 Eingeleitet SVB Leerink Outperform
2020-06-10 Fortgesetzt Piper Sandler Overweight
2020-05-07 Hochstufung JP Morgan Neutral → Overweight
2018-10-05 Eingeleitet JP Morgan Neutral
2018-07-05 Bestätigt Piper Jaffray Overweight
2017-08-07 Bestätigt Morgan Stanley Overweight
2016-11-10 Bestätigt The Benchmark Company Buy
2016-05-23 Bestätigt The Benchmark Company Buy
2016-05-11 Bestätigt The Benchmark Company Buy
2016-04-19 Eingeleitet The Benchmark Company Buy
2015-09-28 Hochstufung Wedbush Neutral → Outperform
2015-08-14 Hochstufung Morgan Stanley Equal-Weight → Overweight
2015-08-04 Eingeleitet Robert W. Baird Outperform
2015-07-27 Eingeleitet Morgan Stanley Equal-Weight
2015-07-27 Eingeleitet Piper Jaffray Overweight
2015-07-27 Eingeleitet Wedbush Neutral
Alle ansehen

Natera Inc Aktie (NTRA) Neueste Nachrichten

pulisher
10:37 AM

Natera stock hits all-time high at 240.96 USD By Investing.com - Investing.com India

10:37 AM
pulisher
Nov 25, 2025

Key facts: JP Morgan raises Natera target; shares rise 2.9%; BV369 Trust to sell 75,000 shares - TradingView

Nov 25, 2025
pulisher
Nov 25, 2025

JP Morgan Raises Price Target for Natera (NTRA) to $250 | NTRA S - GuruFocus

Nov 25, 2025
pulisher
Nov 24, 2025

Natera, GoodRx, and Bio-Techne Shares Are Soaring, What You Need To Know - MSN

Nov 24, 2025
pulisher
Nov 23, 2025

Natera (NTRA): Evaluating Valuation After Q3 Growth, Analyst Upgrades, and OncoEMR Integration - simplywall.st

Nov 23, 2025
pulisher
Nov 22, 2025

Natera co-founder Sheena Jonathan sells $3.17 million in stock By Investing.com - Investing.com Nigeria

Nov 22, 2025
pulisher
Nov 21, 2025

Natera director Baynes sells $2.8 million in shares By Investing.com - Investing.com Canada

Nov 21, 2025
pulisher
Nov 21, 2025

Natera co-founder Sheena Jonathan sells $3.17 million in stock - Investing.com

Nov 21, 2025
pulisher
Nov 21, 2025

Natera director Baynes sells $2.8 million in shares - Investing.com

Nov 21, 2025
pulisher
Nov 21, 2025

Natera, Amneal, Chemed, The Pennant Group, and HCA Healthcare Shares Are Soaring, What You Need To Know - Finviz

Nov 21, 2025
pulisher
Nov 21, 2025

Natera Inc. (NTRA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 21, 2025
pulisher
Nov 21, 2025

First Week of July 2026 Options Trading For Natera (NTRA) - Nasdaq

Nov 21, 2025
pulisher
Nov 21, 2025

Will Natera Inc. stock attract ESG investorsTrade Ideas & Safe Swing Trade Setup Alerts - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Trade Tracker: Stephanie Link buys Natera - MSN

Nov 20, 2025
pulisher
Nov 20, 2025

Is Natera Inc. stock positioned for digital transformationTrade Risk Report & AI Driven Stock Reports - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Spotting Winners: Natera (NASDAQ:NTRA) And Immuno-Oncology Stocks In Q3 - Finviz

Nov 20, 2025
pulisher
Nov 20, 2025

Can Natera Inc. stock withstand economic slowdown2025 Biggest Moves & Community Consensus Picks - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Flatiron Health Integration Expanding Natera's Market Opportunity and Investment Narrative for NTRA? - Yahoo Finance

Nov 20, 2025
pulisher
Nov 19, 2025

Natera at Wolfe Conference: Strategic Growth and Innovation - Investing.com

Nov 19, 2025
pulisher
Nov 19, 2025

How to integrate Natera Inc. into portfolio analysis tools2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Employees Volunteer Over 1,500 Hours During Natera's Annual Volunteer Month - Lelezard

Nov 19, 2025
pulisher
Nov 19, 2025

Will Natera Inc. stock beat EPS estimatesPortfolio Gains Summary & Community Consensus Picks - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Transcript : Natera, Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 01 - MarketScreener

Nov 19, 2025
pulisher
Nov 19, 2025

How Natera Inc. stock reacts to bond yields2025 Trade Ideas & Consistent Growth Equity Picks - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How Investors May Respond To Natera (NTRA) Oncology Test Integration With Flatiron and Upbeat Guidance - simplywall.st

Nov 19, 2025
pulisher
Nov 19, 2025

Employees Volunteer Over 1,500 Hours During Natera’s Annual Volunteer Month - Yahoo Finance

Nov 19, 2025
pulisher
Nov 19, 2025

Is Natera Inc. stock a defensive play in 2025Weekly Profit Summary & Verified Entry Point Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can momentum traders help lift Natera Inc.July 2025 Fed Impact & Free Long-Term Investment Growth Plans - newser.com

Nov 19, 2025

Finanzdaten der Natera Inc-Aktie (NTRA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Natera Inc-Aktie (NTRA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Sheena Jonathan
CO-FOUNDER
Nov 20 '25
Sale
225.08
10,000
2,250,816
222,660
Sheena Jonathan
CO-FOUNDER
Nov 21 '25
Sale
230.01
4,000
920,030
23,282
Baynes Roy D.
Director
Nov 20 '25
Option Exercise
41.17
7,668
315,689
26,027
Baynes Roy D.
Director
Nov 19 '25
Option Exercise
40.93
5,112
209,234
23,471
Baynes Roy D.
Director
Nov 20 '25
Sale
223.08
7,668
1,710,600
18,359
Baynes Roy D.
Director
Nov 19 '25
Sale
215.00
5,112
1,099,088
18,359
diagnostics_research MTD
$1,486.55
price down icon 1.29%
diagnostics_research IQV
$231.80
price down icon 0.05%
diagnostics_research WAT
$407.14
price down icon 1.31%
diagnostics_research LH
$268.27
price down icon 0.58%
diagnostics_research A
$154.37
price down icon 1.80%
Kapitalisierung:     |  Volumen (24h):